Health X Platform Ltd · NSE:HEALTHX
Health X Platform — SastaSundar Ventures — Investor Presentation (May 2017)
39 slides from Health X Platform's investor presentation, May 2017
Slide 1: Investor Presentation May 2017
INVESTOR PRESENTATION May 2017 SastaSundar.com (A Venture of SastaSundar Ventures Limited) 1 Sastasundar.com is a 100% subsidiary of SastaSundar Ventures Limited
Slide 2: Opportunity – Country & Sector (1/2)
OPPORTUNITY – COUNTRY & SECTOR (1/2) INDIAN MARKET POTENTIAL: Retail Pharmacy Diagnostic LAB FMCG 15 Billion USD 06 Billion USD 65 Billion USD Expected Growth Expected Growth Expected Growth 15% CAGR 20% CAGR 14% CAGR Market Share of Organized Players Market Share of Organized Players Market Share o
Slide 3: Opportunity – Country & Sector (2/2)
OPPORTUNITY – COUNTRY & SECTOR (2/2) Walgreens Boots Alliance Why are Walgreens & CVS not present in India? Market CAP – 91 billion USD Small size store CVS Pharmacy Store size of Walgreens is about 25,000 Sq.ft. in comparison to Market CAP – 80 billion USD that India pharmacy store has around 500 S
Slide 4: Company Overview
COMPANY OVERVIEW 4 4
Slide 5: SastaSundar: About Us
SASTASUNDAR : ABOUT US • “Sasta Sundar” is a famous Indian phrase which denotes consumer aspiration for “High Quality at Low Cost”. • We are building Digital Network of Healthcare managing efficient Pharma & Wellness products Supply Chain & connecting Doctors, Diagnostic Services, Healthcare Clinics
Slide 6: Company Snapshot (1/3)
COMPANY SNAPSHOT (1/3) FY17 Product Categories * • SastaSundar Ventures Limited (Previously known as Microsec Own Financial Services Ltd) is a NSE and BSE listed company. Brands Prescribed 5% Medicines • SastaSundar.com started its operations in September, 2013 with a OTC mission to provide low cost
Slide 7: Company Snapshot (2/3)
COMPANY SNAPSHOT (2/3) SASTASUNDAR AT A GLANCE An Online to Offline retailer for genuine Medicines and other high quality OTC & healthcare products All kind of Medicines 172 Healthbuddies including Chronic covering 19 districts of 92% Customer medicines with 5K+ West Bengal around 4.22 Retention Rat
Slide 8: Company Snapshot (3/3)
COMPANY SNAPSHOT (3/3) INDIA’S FASTEST GROWING PHARMACY USD 27mn run rate in JUST 3 years of operations Year wise growth in GMV Fulfilling close to 1,65,000 orders per month GMV (INR Million) No. of orders (Lakhs) 16.86 1,530 9.05 881 2.98 274 FY15 FY16 FY17 FY15 FY16 FY17 Medicine orders constitute
Slide 9: Founders
FOUNDERS B L Mittal (Executive Chairman) Banwari Lal Mittal is a fellow member of the Institute of Chartered Accountants - India, the Institute of Company Secretaries - India and the Institute of Costs and Works Accountants - India. He has over two decades of experience in nurturing businesses. He s
Slide 10: Key Managerial Personnel
KEY MANAGERIAL PERSONNEL Dheer Singh - CTO Dheer is an alumnus of DIT Delhi (now NSIT) in Instrumentation and Control, is a qualified technocrat and seasoned professional. He has rich and successful track record of over 17 years, inclusive of over 7 years of on-site working and Direct (5 years) enga
Slide 11: Competitive Advantage
COMPETITIVE ADVANTAGE Country's 5 ''D'' Company's People Customer Advantage Advantage Advantage Advantage • Mission Oriented • Genuine Medicines & High Drugs Business Quality Healthcare Products • Brand SastaSundar.com • Low Cost • Household relationship ''Being Genuine'' • ‘Free Home Delivery' & Do
Slide 12: Business Overview
BUSINESS OVERVIEW 12 12
Slide 13: Business Overview
BUSINESS OVERVIEW The company is building a Digital Network of Healthcare managing efficient Pharma & Wellness products Supply Chain & connecting Doctors, Diagnostic Services, Healthcare Clinics and Health Information Services. The Network is designed for the following services: 1.Access to Genuine
Slide 14: Business Operation
BUSINESS OPERATION Operation Sequence Order Placement CUSTOMER ONE TIME REGISTRATION LOGIN REORDER PREVIOUS ORDER ORDER PLACED SELECT PRODUCTS Order Processing CITY PHARMA RE-VERIFICATION ORDER SORT / PACK GEN. MEMO SHIPMENT TO HB WAREHOUSE * Re-verification if needed Order Completion HEALTHBUDDY RE
Slide 15: Marketing Strategy
MARKETING STRATEGY APP & Website Counseling using Health information Healthbuddy Counseling Services"Know Health” Search Engine Health Camps Optimization Consumer Gaming Quiz - Digital Engagement is Offline Delivery Van Branding Feedback & connection Online the Key Newspaper Advertisement Social Med
Slide 16: Innovation Leads to Uniqueness
INNOVATION LEADS TO UNIQUENESS Healthbuddy A human face powered by Technology & Centralised inventory offer, services at low cost. Emotional connect & counseling ensures lowest cost of customer acquisition and high degree of repeat orders. Technology Edge •The Artificial intelligence based upon Dise
Slide 17: Distribution Network
DISTRIBUTION NETWORK SastaSundar In WEST BENGAL • Covering the state of West Bengal all 19 Districts. • Elevation Centre is located at Kolkata, having Covering 19 around 172 healthbuddy center located at Districts of every 3 km of radius. West Bengal with • Covering 4.22 Lakh households 172 healthbu
Slide 18: Superior Technological Edge
SUPERIOR TECHNOLOGICAL EDGE Health Condition Data and Analytics • The Artificial intelligence based upon Disease bare data made us capable to provide consumer centric Personal servicing. Input Output • A diabetic patient can see diabetic related information • Patient • Location wise Disease through
Slide 19: Efficient Inventory Management
EFFICIENT INVENTORY MANAGEMENT • Efficient and low cost inventory management to ensure higher Procurement profitability and low risk profile. at Elevation Healthbuddy • Since 90% sales of medicines are for chronic diseases, reorder Centre Process by delivers the every 15 days expected sale is done a
Slide 20: Vendor Selection and Procurement Process
VENDOR SELECTION AND PROCUREMENT PROCESS SastaSundar targets the Pharma Companies and their distributor for purchase of medicines Vendor Identification process for OTC products Chronic and Generic Business Information shared medicines Intelligence Team with vendor Identification Identifies Fast acqu
Slide 21: Customer Centric Approach
CUSTOMER CENTRIC APPROACH Value to Customers Accessibility Affordability Convenience Mobile app is available in Android, IOS and Windows. Structured Information about medication, Reorder reminder tools their effects and side effects Personalized customer interface, dashboard and integration of digit
Slide 22: Own Brands (1/2)
OWN BRANDS (1/2) • DNAVITA (Customized Health Supplement Made of Natural Ingredients): DNAVITA is a customised health drink "Made for You" to provide Nutrition including Vitamins and Minerals considering your health condition, age, height, weight, food habits and lifestyle using Natural Ingredients
Slide 23: Own Brands (2/2)
OWN BRANDS (2/2) • HealthBuddy CARE: A varied range of products, starting from wellness to hygiene, from cleanliness to elderly care. The product range is hygienic and designed to simplify the essential requirements of day-to-day life while maintaining quality and comfort. • Stoptar: A boon for thos
Slide 24: Strategic Overview
STRATEGIC OVERVIEW 24 24
Slide 25: Vision 2024
VISION 2024 Industry leading analytics best positioned for Pan India delivery network with USD 1 Ready for doctors, Global Companies Pharma Scale and diagnostic billion sales and 15% EBIDTA with high leads Return on Investment & High Growth Platform to launch and distribute A portfolio of own digita
Slide 26: Future Growth Strategy
FUTURE GROWTH STRATEGY Meaning of the Green Lines The green color line Built Model indicates our approach to & Brand validate before we take next SastaSundar stage. in one state in Pharma & FMCG With approach of ‘Think Big product line Act Small ’ , we keep our eyes on High Growth with operational e
Slide 27: Revenue Matrix & Economic Assets
REVENUE MATRIX & ECONOMIC ASSETS Contribution from selling of third party medicines Brand SastaSundar Contribution from selling of third party wellness products Contribution from selling of our products under Aspiration brand Our Digital Economic Healthbuddy Connectivity Network Contribution from li
Slide 28: Building Scale to Increase Profitability
BUILDING SCALE TO INCREASE PROFITABILITY Volume based discounting Inflexion Point 1. Larger scale will gives SastaSundar significant advantage to negotiate bulk discounts with distributors thereby improving their profitability Revenue Provides Negotiation Edge Profits 1. Higher scale offers signific
Slide 29: Creating a Database of Health Condition and Analytics
CREATING A DATABASE OF HEALTH CONDITION AND ANALYTICS Know Health Health Information Services Connect Services Symptoms Doctors Checker Appointment Health Health Articles Tools Wellness Telemedicine Service (Consultation Provider via video) Medicine Info & Emergency Substitute Handling LAB Tests Hos
Slide 30: SastaSundar – Market Penetration Strategy
SASTASUNDAR – MARKET PENETRATION STRATEGY Entry Create a Efficient Guaranteed through trusted centralized Entry next-day Create HB network medicines – a brand with procurement deliveries into City critical and HB presence leads to and Customer base and best repeating and quality highest fill prices
Slide 31: SastaSundar – Target Market
SASTASUNDAR – TARGET MARKET Top 10 Cities and Neighboring Cities /Towns City Population 2014 (Mn) Mumbai 25 These 10 Target cities Top 10 cities contribute to would have 1 10% of India’s Population Delhi / NCR 24 warehouse each New Delhi Kolkata 15 Hyderabad 11 Jaipur Bengaluru 11 Ahmedabad Each war
Slide 32: Financial Overview
FINANCIAL OVERVIEW 32 32
Slide 33: Income Statement of Subsidiary SastaSundar Healthbuddy Ltd
INCOME STATEMENT OF SUBSIDIARY SASTASUNDAR HEALTHBUDDY LTD Particulars (INR Mn) FY13 FY14 FY15 FY16 FY17 Total Revenue* 9 10 207 638 1,121 Total Expenses 11 41 302 838 1,354 EBITDA -2 -31 -95 -200 -233 Depreciation 1 2 17 41 41 Finance Cost 0 0 0 6 19 Profit/Loss Before Tax -3 -33 -112 -247 -293 Tax
Slide 34: Consolidated Income Statement
CONSOLIDATED INCOME STATEMENT Particulars (INR in MN) FY13 FY14 FY15 FY16 FY17 Revenue from Operations 450 267 483 862 1,329 Other Income 26 39 42 28 41 Total Expenses 321 348 624 1,175 1,553 EBITDA 155 -42 -99 -285 -183 Depreciation 17 19 57 73 69 Finance Costs 11 6 9 10 28 Exceptional Items - - 17
Slide 35: Consolidated Balance Sheet
CONSOLIDATED BALANCE SHEET Application of Funds (INR in Sources of Funds (INR in Mn) FY 14 FY 15 FY16 FY17 FY 14 FY 15 FY16 FY17 Mn) Equity & Liabilities Tangible Assets 589 775 662 652 Shareholder's Fund Intangible Assets 580 600 600 596 Share Capital 318 318 318 318 Assets held for disposal - - -
Slide 36: Capital Market Data
CAPITAL MARKET DATA 60% Sastasundar Sensex Price Data (31st March, 2017) INR 50% 40% Face Value 10 30% 20% Market Price 99 10% 0% 52 Week H/L (INR) 111.25/43.2 -10% -20% Market Cap (INR Mn) 3149 -30% -40% Equity Shares Outstanding (Mn) 31.81 1 Year Avg. trading Volume ('000) 42.34 Share Holding Patt
Slide 37: The Great Business Can Only Be Built by Solving Any Problem
THE GREAT BUSINESS CAN ONLY BE BUILT BY SOLVING ANY PROBLEM AND IF WE NEED TO SOLVE THE PROBLEM, LET US SOLVE THE BIGGER PROBLEM 37
Slide 38: Thank You
Thank You 38 Health & Happiness
Slide 39: Disclaimer
DISCLAIMER Sastasundar.com This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sastasundar.com (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for an
SastaSundar Ventures — Investor Presentation (May 2017) on 6ix